Green Thumb Industries Announces Conference Participation for December 2022

CHICAGO and VANCOUVER, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced its executive team will participate in the following conference in December 2022:

Cowen 5th Annual Cannabis Conference (Virtual), December 6, 2022: Management will participate in one-on-one meetings and Ben Kovler, Green Thumb Founder, Chairman and Chief Executive Officer, will participate in a fireside chat with Vivien Azer, Managing Director and senior research analyst specializing in the beverages, tobacco, and cannabis sectors.

About Green Thumb Industries:Green Thumb Industries Inc. (“Green Thumb”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles and RYTHM. The company also owns and operates rapidly growing national retail cannabis stores called RISE. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities, 77 open retail locations and operations across 15 U.S. markets. Established in 2014, Green Thumb employs approximately 3,800 people and serves millions of patients and customers each year. The company was named to Crain’s Chicago Business Fast 50 list in 2021 and 2022 and a Best Workplace by MG Retailer magazine in 2018, 2019 and 2021. More information is available www.GTIgrows.com.

Investor Contact:Andy GrossmanEVP, Capital Markets & Investor Relations[email protected] 310-622-8257

Media Contact:MATTIO Communications[email protected]

Source: Green Thumb Industries

You May Also Be Interested In

• CivicLabs Launches Global Business Development Platform to Help Built Environment Startups Scale Up and Enter New Markets
• FORTÉ Acquires Vega Global, APAC's Largest Systems Integrator, Expanding Global Reach
• Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment